Compounded Tirzepatide Injections

Tirzepatide is a dual-pathway medication that targets GLP-1 and GIP receptor signaling¹ — two hormone pathways involved in appetite regulation and blood sugar control. In a clinician-guided program it may help support appetite regulation and fullness for some people.³

Adults a licensed provider determines are clinically appropriate after reviewing your health history. Eligibility is decided by the provider, not by us — not everyone qualifies, and tirzepatide is not right for everyone.

If the provider decides treatment is not appropriate for you, there is nothing to pay.

One monthly price covering the medication itself, your provider review and prescription, discreet refrigerated shipping, and ongoing access to the clinical team. No separate medication charge and no hidden fees.

To get started, complete an online intake about your health history and goals. A licensed provider reviews it and prescribes if appropriate. Refills and dose adjustments are coordinated with your care team.

One subcutaneous injection per week, any day, with or without meals.¹ Your provider starts you at a low dose and steps it up gradually to limit side effects.

• Once-weekly injection Tirzepatide is taken as a subcutaneous injection one time per week, any day, with or without meals.¹
• Gradual dose titration Your provider starts you at a low dose and increases gradually over the first weeks to minimize side effects.
• Rotate injection sites Rotate between thigh, abdomen, and upper arm to reduce site reactions and discomfort.
• Missed dose guidance If a dose is missed and it has been less than 3 days, take it as soon as possible. Otherwise skip and resume your schedule. When in doubt, message your care team before dosing.

Most people tolerate treatment well, and side effects are usually most noticeable in the first few weeks. Your provider helps you manage them and adjusts your plan if needed.

• Common side effects Nausea, fatigue, decreased appetite, occasional diarrhea or constipation — most pronounced during the first 2–4 weeks.¹
• When they subside For most people, side effects ease as your body adjusts to the medication and at stable dose levels.
• When to contact your provider Severe abdominal pain, signs of allergic reaction, vision changes, or persistent vomiting require immediate provider contact.
• Not for everyone Tirzepatide is not appropriate for people with a personal or family history of medullary thyroid carcinoma or MEN 2.¹

Your medication ships in refrigerated packaging and needs to stay cold between doses.

• Refrigeration Store at 36–46°F (2–8°C) in the original carton. Keep the medication in the refrigerator between doses.¹
• Protect from light Keep in the original packaging until use to protect the medication from light exposure.
• Do not freeze If your medication freezes or is exposed to extreme heat, discard it and contact our team for a replacement.
• Travel guidance Medication is stable at room temperature for limited periods during travel. Use an insulated cooler for longer trips.